Phase I clinical trial of antimesothelin immunotoxin SS1P in combination with pemetrexed and cisplatin for front-line therapy of advanced pleural mesothelioma

被引：0
|
作者：
Hassan, R.
Sharon, E.
Chen, H. X.
Conlon, K.
Ling, A.
Steinberg, S. M.
Pastan, I.
机构：
[1] NCI, Bethesda, MD 20892 USA
[2] NCI, CTEP, Bethesda, MD 20892 USA
[3] NIH, Bethesda, MD 20892 USA
[4] NCI, Biostat & Data Management Sect, Bethesda, MD 20892 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e17518
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Phase 1 Study of the Antimesothelin Immunotoxin SS1P in Combination With Pemetrexed and Cisplatin for Front-Line Therapy of Pleural Mesothelioma and Correlation of Tumor Response With Serum Mesothelin, Megakaryocyte Potentiating Factor, and Cancer Antigen 125
    Hassan, Raffit
    Sharon, Elad
    Thomas, Anish
    Zhang, Jingli
    Ling, Alexander
    Miettinen, Markku
    Kreitman, Robert J.
    Steinberg, Seth M.
    Hollevoet, Kevin
    Pastan, Ira
    CANCER, 2014, 120 (21) : 3311 - 3319
  • [2] Antitumor activity of SS1P with pemetrexed and cisplatin for front-line treatment of pleural mesothelioma and utility of serum mesothelin as a marker of tumor response.
    Hassan, R.
    Sharon, E.
    Schuler, B.
    Mallory, Y.
    Zhang, J.
    Ling, A.
    Pastan, I.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [3] Phase II Clinical Trial of Amatuximab, a Chimeric Antimesothelin Antibody with Pemetrexed and Cisplatin in Advanced Unresectable Pleural Mesothelioma
    Hassan, Raffit
    Kindler, Hedy L.
    Jahan, Thierry
    Bazhenova, Lyudmila
    Reck, Martin
    Thomas, Anish
    Pastan, Ira
    Parno, Jeff
    O'Shannessy, Daniel J.
    Fatato, Penny
    Maltzman, Julia D.
    Wallin, Bruce A.
    CLINICAL CANCER RESEARCH, 2014, 20 (23) : 5927 - 5936
  • [4] A randomized, placebo-controlled study of amatuximab in combination with pemetrexed and cisplatin (P/C) as front-line therapy for subjects with malignant pleural mesothelioma (MPM).
    Hassan, Raffit
    Fennell, Dean
    Scherpereel, Arnaud
    Nowak, Anna K.
    Von Pawel, Joachim
    Novello, Silvia
    McLaughlin, Megan
    Hoffman, Kimberly
    Wallin, Bruce A.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [5] A phase 2 clinical trial of pemetrexed plus gemcitabine as front-line chemotherapy for patients with malignant pleural mesothelioma (MPM).
    Janne, PA
    Obasaju, C
    Simon, G
    Taub, R
    Kelly, K
    Fidias, P
    Bloss, LP
    Kindler, HL
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 629S - 629S
  • [6] An update of pemetrexed (P) plus gemcitabine (G) as front-line chemotherapy for patients (pts) with malignant pleural mesothelioma (MPM): A phase II clinical trial
    Janne, PA
    Simon, GR
    Langer, CJ
    Taub, RN
    Dowlati, A
    Fidias, P
    Bloss, LP
    Ye, Z
    Obasaju, C
    Kindler, HL
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 637S - 637S
  • [7] An update of pemetrexed (P) plus gemcitabine (G) as front-line chemotherapy for patients (pts) with malignant pleural mesothelioma (MPM): A phase II clinical trial
    Janne, P
    Simon, G
    Langer, C
    Taub, R
    Dowlati, A
    Fidias, P
    Bloss, L
    Ye, Z
    Obasaju, C
    Kindler, H
    LUNG CANCER, 2005, 49 : S282 - S282
  • [8] Phase I Trial of Continuous Infusion Anti-Mesothelin Recombinant Immunotoxin SS1P
    Kreitman, Robert J.
    Hassan, Raffit
    FitzGerald, David J.
    Pastan, Ira
    CLINICAL CANCER RESEARCH, 2009, 15 (16) : 5274 - 5279
  • [9] A phase 2 clinical trial of pemetrexed (P) plus gemcitabine (G) as front-line chemotherapy for patients with peritoneal mesothelioma (PM).
    Simon, GR
    Janne, PA
    Langer, CJ
    Verschraegen, CF
    Dowlati, A
    Gadgeel, SM
    Kelly, K
    Taylor, L
    Obasaju, CK
    Kindler, HL
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 679S - 679S
  • [10] Phase II study of pemetrexed with and without folic acid and vitamin B12 as front-line therapy in malignant pleural mesothelioma
    Scagliotti, GV
    Shin, DM
    Kindler, HL
    Vasconcelles, MJ
    Keppler, U
    Manegold, C
    Burris, H
    Gatzemeier, U
    Blatter, J
    Symanowski, JT
    Rusthoven, JJ
    JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (08) : 1556 - 1561
12345